Twenty out of twenty-one biopsies obtained prior to start of ELX/TEZ/IVA-treatment displayed such a mutant CFTR C* signal and the typical shape of complex glycosylated wild-type CFTR band C was absent in all analyzed CF biopsies (Figure 2A; Supplementary Figure S2). This evidence concerns the gene CFTR and cystic fibrosis.